ArticleBMC infectious diseases2025
Hospitalizations trends and co-infection patterns for respiratory virus infections in children in central China 2015 to 2023: a longitudinal surveillance study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- The pathogen spectrum of influenza-like illness in Guilin, China, 2023-2024.Frontiers in public health · 2026Article
- Epidemiology of respiratory syncytial virus in a German hospital before, during and after the COVID-19 pandemic - a real world monocentric analysis over ten years.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive epidemiological analysis of respiratory viral infections in Henan Province, China, from 2015 to 2023, encompassing 183,771 reported cases. The predominant pathogens included influenza A virus (Flu A), accounting for 58.66% of infections, followed by influenza B virus (Flu B), respiratory syncytial virus (RSV), parainfluenza virus (PIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human rhinovirus (HRV), was 19.44%, 12.00%, 9.10%, 0.44%, and 0.37%, respectively. A significantly higher detection rate was observed in males compared to females (57.22% vs. 42.78%; χ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.